Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald L DeNardo

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Editorial: "right place, wrong place": extravasation of therapeutic drug for molecular targeted radiotherapyGerald L Denardo
Clinical Lymphoma|October 23, 2004
New directions in radioimmunotherapy of non-Hodgkin's lymphomaGerald L DeNardo
Seminars in Oncology|March 24, 2005
Concepts in radioimmunotherapy and immunotherapy: Radioimmunotherapy from a Lym-1 perspectiveGerald L DeNardo
Cancer Biotherapy & Radiopharmaceuticals|December 27, 2007
The conundrum of personalized cancer management, drug development, and economicsGerald L DeNardo
Seminars in Nuclear Medicine|August 16, 2005
Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs)Gerald L DeNardo
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Targeted radionuclide therapy for solid tumors: an overviewSally J DeNardo, Gerald L Denardo
Cancer Biotherapy & Radiopharmaceuticals|September 21, 2010
Pretherapy prediction of nephrotoxicity after peptide radionuclide receptor therapy (PRRT)Gerald L Denardo, Daniel J Macey
Cancer Biotherapy & Radiopharmaceuticals|May 7, 2010
Update: Turning the heat on cancerGerald L DeNardo, Sally J DeNardo
Seminars in Nuclear Medicine|April 6, 2012
Concepts, consequences, and implications of theranosisGerald L DeNardo, Sally J DeNardo
Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
Health care in the United States in 2009: both sides of the "counter"Gerald L DeNardo, Sally J DeNardo
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
Editorial: "right place, wrong place": extravasation of therapeutic drug for molecular targeted radiotherapyGerald L Denardo
Clinical Lymphoma|October 23, 2004
New directions in radioimmunotherapy of non-Hodgkin's lymphomaGerald L DeNardo
Seminars in Oncology|March 24, 2005
Concepts in radioimmunotherapy and immunotherapy: Radioimmunotherapy from a Lym-1 perspectiveGerald L DeNardo
Cancer Biotherapy & Radiopharmaceuticals|December 27, 2007
The conundrum of personalized cancer management, drug development, and economicsGerald L DeNardo
Seminars in Nuclear Medicine|August 16, 2005
Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs)Gerald L DeNardo
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Targeted radionuclide therapy for solid tumors: an overviewSally J DeNardo, Gerald L Denardo
Cancer Biotherapy & Radiopharmaceuticals|September 21, 2010
Pretherapy prediction of nephrotoxicity after peptide radionuclide receptor therapy (PRRT)Gerald L Denardo, Daniel J Macey
Cancer Biotherapy & Radiopharmaceuticals|May 7, 2010
Update: Turning the heat on cancerGerald L DeNardo, Sally J DeNardo
Seminars in Nuclear Medicine|April 6, 2012
Concepts, consequences, and implications of theranosisGerald L DeNardo, Sally J DeNardo
Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
Health care in the United States in 2009: both sides of the "counter"Gerald L DeNardo, Sally J DeNardo
Pageof 7